| - Industry | - Sector | - CEO | TWSE Exchange | - ISIN |
| Taiwan Country | 98 Employees | - Last Dividend | 21 Jul 2025 Last Split | - IPO Date |
Spirit Scientific Co., Ltd. is a pioneering biotechnology company that excels in the development and commercialization of cutting-edge regenerative medical technologies. Positioned at the forefront of innovation, the company is dedicated to advancing the field of personalized medicine through a core emphasis on platelet-lyophilized technology and the preparation of autologous regenerative reagents. With a specific focus on orthopedics and pain management, Spirit Scientific is committed to delivering transformative solutions that enhance patient outcomes. The company proudly introduces innovative products like Vessel-X, a specialized bone filling system designed explicitly for spinal compression fractures, alongside platelet-based therapeutic options aimed at addressing osteoarthritis and sports-related injuries. Through the utilization of patented platelet-lyophilization processes, Spirit Scientific manufactures high-purity, shelf-stable platelet preparations that are essential for personalized treatment modalities. As a key player in Taiwan’s biotechnology and medical research landscape, Spirit Scientific is actively fostering the advancement of minimally invasive treatments and making significant contributions to the burgeoning field of regenerative therapies in healthcare.
Vessel-X is an innovative bone filling system specifically designed for treating spinal compression fractures. This product utilizes advanced regenerative technologies to provide effective support and enhancement of recovery, aiming to restore mobility and reduce pain for patients suffering from such fractures.
These solutions are formulated to target conditions such as osteoarthritis and sports injuries. By leveraging the unique properties of platelet preparations, these therapies aim to promote healing and recovery by harnessing the body's natural regenerative capabilities.
Spirit Scientific employs patented processes to create high-purity, shelf-stable platelet preparations. These advanced methodologies ensure that therapeutic products maintain their efficacy and can be conveniently utilized in various clinical settings, enabling personalized treatment approaches for patients.
In addition to product development, Spirit Scientific engages in collaborative clinical research efforts aimed at exploring new applications for regenerative therapies. These collaborations help advance the understanding and effectiveness of their innovative solutions within the medical community.
The company offers specialized manufacturing services for blood components, ensuring high-quality production that adheres to strict medical standards. This service is crucial for the development of targeted regenerative treatments.
Spirit Scientific provides expert consultancy services for the design and construction of biomaterial laboratories. This assistance is geared towards organizations aiming to establish cutting-edge facilities that support innovative research and product development in the field of biotechnology.
The company operates a fully equipped biotechnology laboratory focused on standardizing and scaling proprietary processes. This dedicated space enables rigorous testing and development of new regenerative medical technologies, fostering continuous innovation and improvement.